Mycovia Pharmaceuticals Inc.
Mycovia Pharmaceuticals is developing therapies to treat yeast and fungal infections.
Company Location
4721 Emperor Blvd., Sutie 220
Durham
NC
27703
Phone
County
Region
Company Details
Company type
Year founded
2018
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products on market
VIVJOA® (oteseconazole) is indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential.
Products under development
VT-1161 for Recurrent Vulvovaginal Candidiasis (RVVC)